title: Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation.
authors.forename: Christina
authors.initials: C
authors.lastname: Berens
authors.affiliation: Heiko Rühl, MD, Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany, Tel.: +49 228 287 16725, Fax: +49 228 287 14783, E-mail: heiko.ruehl@ukb.uni-bonn.de.
authors.forename: Heiko
authors.initials: H
authors.lastname: Rühl
authors.forename: Vytautas
authors.initials: V
authors.lastname: Ivaškevičius
authors.forename: Johannes
authors.initials: J
authors.lastname: Oldenburg
authors.forename: Hans-Jörg
authors.initials: HJ
authors.lastname: Hertfelder
authors.forename: Bernd
authors.initials: B
authors.lastname: Pötzsch
mesh_terms: D000293:Adolescent; D000347:Afibrinogenemia / Q000150:complications* / Q000188:drug therapy / Q000235:genetics*; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005340:Fibrinogen / Q000008:administration & dosage / Q000235:genetics* / Q000627:therapeutic use; D015241:Fibrinogens, Abnormal / Q000235:genetics*; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006579:Heterozygote; D006801:Humans; D009154:Mutation; D012008:Recurrence; D054556:Venous Thromboembolism / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics*
chemical_list: D000925:Anticoagulants; D015241:Fibrinogens, Abnormal; C464794:fibrinogen Aalpha; D005340:Fibrinogen